10 20 30 40 50 60 70 80 2DXT - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER LIGASE 30-AUG-06 2DXT
TITLE CRYSTAL STRUCTURE OF BIOTIN PROTEIN LIGASE FROM PYROCOCCUS TITLE 2 HORIKOSHII COMPLEXED WITH ATP AND BIOTIN, MUTATION D104A
COMPND MOL_ID: 1; COMPND 2 MOLECULE: BIOTIN--[ACETYL-COA-CARBOXYLASE] LIGASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: BIOTIN PROTEIN LIGASE; COMPND 5 EC: 6.3.4.15; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PYROCOCCUS HORIKOSHII; SOURCE 3 ORGANISM_TAXID: 53953; SOURCE 4 GENE: BIRA; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: (DE3)RIL; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET 11A
KEYWDS BIOTIN BIOSYNTHESIS, DIMER, STRUCTURAL GENOMICS, NPPSFA, KEYWDS 2 NATIONAL PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL KEYWDS 3 ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, KEYWDS 4 RSGI, LIGASE
EXPDTA X-RAY DIFFRACTION
AUTHOR B.BAGAUTDINOV,Y.MATSUURA,N.KUNISHIMA,RIKEN STRUCTURAL AUTHOR 2 GENOMICS/PROTEOMICS INITIATIVE (RSGI)
REVDAT 2 24-FEB-09 2DXT 1 VERSN REVDAT 1 01-MAR-07 2DXT 0
JRNL AUTH B.BAGAUTDINOV,Y.MATSUURA,N.KUNISHIMA JRNL TITL LIGAND STRUCTURES OF BIOTIN PROTEIN LIGASE FROM JRNL TITL 2 PYROCOCCUS HORIKOSHII OT3 JRNL REF TO BE PUBLISHED JRNL REFN
REMARK 1
REMARK 2 REMARK 2 RESOLUTION. 1.60 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 37.23 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 90.8 REMARK 3 NUMBER OF REFLECTIONS : 51912 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.188 REMARK 3 FREE R VALUE : 0.201 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 2572 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3668 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 94 REMARK 3 SOLVENT ATOMS : 564 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 21.24 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.05000 REMARK 3 B22 (A**2) : -6.61000 REMARK 3 B33 (A**2) : 7.66000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 2.02000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.18 REMARK 3 ESD FROM SIGMAA (A) : 0.17 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.20 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.18 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.30 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.80 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.89 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : OVERALL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 2DXT COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 01-SEP-06. REMARK 100 THE RCSB ID CODE IS RCSB025976.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-JUL-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SPRING-8 REMARK 200 BEAMLINE : BL26B1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 51912 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.600 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 90.8 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : 0.04900 REMARK 200 R SYM (I) : 0.04500 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 19.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.66 REMARK 200 COMPLETENESS FOR SHELL (%) : 74.7 REMARK 200 DATA REDUNDANCY IN SHELL : 2.60 REMARK 200 R MERGE FOR SHELL (I) : 0.25900 REMARK 200 R SYM FOR SHELL (I) : 0.21800 REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: CNS 1.1 REMARK 200 STARTING MODEL: 1WQW REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.40 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.14 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG20K, ACETATE, NAOH, ATP, BIOTIN, REMARK 280 PH 5.2, MICROBATCH, TEMPERATURE 295K
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 41.41300 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL UNIT IS A DIMER AND IDENTICAL TO THE REMARK 300 ASYMMETRIC UNIT
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4790 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19960 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 1.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 TRP A 101 NE1 TRP A 101 CE2 0.114 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 8 -60.27 -122.49 REMARK 500 VAL A 132 -79.32 -108.52 REMARK 500 ASP A 206 -172.67 177.94 REMARK 500 ASP A 229 48.07 -101.80 REMARK 500 ILE B 8 -58.33 -120.95 REMARK 500 LEU B 49 -140.25 54.10 REMARK 500 ASN B 50 41.27 -106.65 REMARK 500 VAL B 132 -78.54 -112.21 REMARK 500 PRO B 152 108.62 -58.41 REMARK 500 SER B 199 153.92 -49.40 REMARK 500 ASP B 206 -175.08 -177.44 REMARK 500 REMARK 500 REMARK: NULL
REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1605 DISTANCE = 7.00 ANGSTROMS REMARK 525 HOH A1631 DISTANCE = 5.61 ANGSTROMS REMARK 525 HOH B1672 DISTANCE = 6.20 ANGSTROMS REMARK 525 HOH B1673 DISTANCE = 5.55 ANGSTROMS REMARK 525 HOH B1674 DISTANCE = 6.22 ANGSTROMS REMARK 525 HOH A1680 DISTANCE = 6.21 ANGSTROMS REMARK 525 HOH A1689 DISTANCE = 5.54 ANGSTROMS
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ATP A 1301 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ATP B 1302 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BTN A 1401 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BTN B 1402
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1WQW RELATED DB: PDB REMARK 900 THE APO-PROTEIN COMPLEXED WITH BIOTINYL-5'-AMP REMARK 900 RELATED ID: 2DXU RELATED DB: PDB REMARK 900 RELATED ID: PHO001000147.15 RELATED DB: TARGETDB
DBREF 2DXT A 1 235 UNP O57883 O57883_PYRHO 1 235 DBREF 2DXT B 1 235 UNP O57883 O57883_PYRHO 1 235
SEQADV 2DXT ALA A 104 UNP O57883 ASP 104 ENGINEERED SEQADV 2DXT ALA B 104 UNP O57883 ASP 104 ENGINEERED
SEQRES 1 A 235 MET LEU GLY LEU LYS THR SER ILE ILE GLY ARG ARG VAL SEQRES 2 A 235 ILE TYR PHE GLN GLU ILE THR SER THR ASN GLU PHE ALA SEQRES 3 A 235 LYS THR SER TYR LEU GLU GLU GLY THR VAL ILE VAL ALA SEQRES 4 A 235 ASP LYS GLN THR MET GLY HIS GLY ARG LEU ASN ARG LYS SEQRES 5 A 235 TRP GLU SER PRO GLU GLY GLY LEU TRP LEU SER ILE VAL SEQRES 6 A 235 LEU SER PRO LYS VAL PRO GLN LYS ASP LEU PRO LYS ILE SEQRES 7 A 235 VAL PHE LEU GLY ALA VAL GLY VAL VAL GLU THR LEU LYS SEQRES 8 A 235 GLU PHE SER ILE ASP GLY ARG ILE LYS TRP PRO ASN ALA SEQRES 9 A 235 VAL LEU VAL ASN TYR LYS LYS ILE ALA GLY VAL LEU VAL SEQRES 10 A 235 GLU GLY LYS GLY ASP LYS ILE VAL LEU GLY ILE GLY LEU SEQRES 11 A 235 ASN VAL ASN ASN LYS VAL PRO ASN GLY ALA THR SER MET SEQRES 12 A 235 LYS LEU GLU LEU GLY SER GLU VAL PRO LEU LEU SER VAL SEQRES 13 A 235 PHE ARG SER LEU ILE THR ASN LEU ASP ARG LEU TYR LEU SEQRES 14 A 235 ASN PHE LEU LYS ASN PRO MET ASP ILE LEU ASN LEU VAL SEQRES 15 A 235 ARG ASP ASN MET ILE LEU GLY VAL ARG VAL LYS ILE LEU SEQRES 16 A 235 GLY ASP GLY SER PHE GLU GLY ILE ALA GLU ASP ILE ASP SEQRES 17 A 235 ASP PHE GLY ARG LEU ILE ILE ARG LEU ASP SER GLY GLU SEQRES 18 A 235 VAL LYS LYS VAL ILE TYR GLY ASP VAL SER LEU ARG PHE SEQRES 19 A 235 LEU SEQRES 1 B 235 MET LEU GLY LEU LYS THR SER ILE ILE GLY ARG ARG VAL SEQRES 2 B 235 ILE TYR PHE GLN GLU ILE THR SER THR ASN GLU PHE ALA SEQRES 3 B 235 LYS THR SER TYR LEU GLU GLU GLY THR VAL ILE VAL ALA SEQRES 4 B 235 ASP LYS GLN THR MET GLY HIS GLY ARG LEU ASN ARG LYS SEQRES 5 B 235 TRP GLU SER PRO GLU GLY GLY LEU TRP LEU SER ILE VAL SEQRES 6 B 235 LEU SER PRO LYS VAL PRO GLN LYS ASP LEU PRO LYS ILE SEQRES 7 B 235 VAL PHE LEU GLY ALA VAL GLY VAL VAL GLU THR LEU LYS SEQRES 8 B 235 GLU PHE SER ILE ASP GLY ARG ILE LYS TRP PRO ASN ALA SEQRES 9 B 235 VAL LEU VAL ASN TYR LYS LYS ILE ALA GLY VAL LEU VAL SEQRES 10 B 235 GLU GLY LYS GLY ASP LYS ILE VAL LEU GLY ILE GLY LEU SEQRES 11 B 235 ASN VAL ASN ASN LYS VAL PRO ASN GLY ALA THR SER MET SEQRES 12 B 235 LYS LEU GLU LEU GLY SER GLU VAL PRO LEU LEU SER VAL SEQRES 13 B 235 PHE ARG SER LEU ILE THR ASN LEU ASP ARG LEU TYR LEU SEQRES 14 B 235 ASN PHE LEU LYS ASN PRO MET ASP ILE LEU ASN LEU VAL SEQRES 15 B 235 ARG ASP ASN MET ILE LEU GLY VAL ARG VAL LYS ILE LEU SEQRES 16 B 235 GLY ASP GLY SER PHE GLU GLY ILE ALA GLU ASP ILE ASP SEQRES 17 B 235 ASP PHE GLY ARG LEU ILE ILE ARG LEU ASP SER GLY GLU SEQRES 18 B 235 VAL LYS LYS VAL ILE TYR GLY ASP VAL SER LEU ARG PHE SEQRES 19 B 235 LEU
HET ATP A1301 31 HET ATP B1302 31 HET BTN A1401 16 HET BTN B1402 16
HETNAM ATP ADENOSINE-5'-TRIPHOSPHATE HETNAM BTN BIOTIN
FORMUL 3 ATP 2(C10 H16 N5 O13 P3) FORMUL 5 BTN 2(C10 H16 N2 O3 S) FORMUL 7 HOH *564(H2 O)
HELIX 1 1 SER A 21 SER A 29 1 9 HELIX 2 2 GLY A 47 ARG A 51 5 5 HELIX 3 3 PRO A 71 PRO A 76 5 6 HELIX 4 4 LYS A 77 PHE A 93 1 17 HELIX 5 5 SER A 142 GLY A 148 1 7 HELIX 6 6 PRO A 152 ASN A 174 1 23 HELIX 7 7 MET A 176 MET A 186 1 11 HELIX 8 8 SER B 21 SER B 29 1 9 HELIX 9 9 PRO B 71 PRO B 76 5 6 HELIX 10 10 LYS B 77 PHE B 93 1 17 HELIX 11 11 SER B 142 GLY B 148 1 7 HELIX 12 12 PRO B 152 ASN B 174 1 23 HELIX 13 13 MET B 176 MET B 186 1 11
SHEET 1 A14 ARG A 98 LYS A 100 0 SHEET 2 A14 ALA A 104 VAL A 107 -1 O LEU A 106 N ARG A 98 SHEET 3 A14 LYS A 110 LYS A 120 -1 O ILE A 112 N VAL A 105 SHEET 4 A14 LYS A 123 LEU A 130 -1 O VAL A 125 N GLU A 118 SHEET 5 A14 LEU A 60 LEU A 66 -1 N LEU A 66 O ILE A 124 SHEET 6 A14 VAL A 36 ALA A 39 -1 N ILE A 37 O SER A 63 SHEET 7 A14 ARG A 12 PHE A 16 1 N ILE A 14 O VAL A 36 SHEET 8 A14 ARG B 12 ILE B 19 -1 O TYR B 15 N VAL A 13 SHEET 9 A14 VAL B 36 GLN B 42 1 O VAL B 36 N ILE B 14 SHEET 10 A14 LEU B 60 LEU B 66 -1 O SER B 63 N ILE B 37 SHEET 11 A14 LYS B 123 LEU B 130 -1 O ILE B 124 N LEU B 66 SHEET 12 A14 LYS B 110 LYS B 120 -1 N GLU B 118 O VAL B 125 SHEET 13 A14 ALA B 104 VAL B 107 -1 N VAL B 105 O ILE B 112 SHEET 14 A14 ARG B 98 LYS B 100 -1 N ARG B 98 O LEU B 106 SHEET 1 B 5 VAL A 222 VAL A 225 0 SHEET 2 B 5 LEU A 213 ARG A 216 -1 N LEU A 213 O VAL A 225 SHEET 3 B 5 SER A 199 ILE A 207 -1 N ASP A 206 O ILE A 214 SHEET 4 B 5 ARG A 191 LEU A 195 -1 N VAL A 192 O GLY A 202 SHEET 5 B 5 SER A 231 PHE A 234 -1 O SER A 231 N LEU A 195 SHEET 1 C 5 VAL B 222 VAL B 225 0 SHEET 2 C 5 LEU B 213 ARG B 216 -1 N LEU B 213 O VAL B 225 SHEET 3 C 5 PHE B 200 ILE B 207 -1 N ASP B 206 O ILE B 214 SHEET 4 C 5 VAL B 190 ILE B 194 -1 N VAL B 192 O GLY B 202 SHEET 5 C 5 LEU B 232 PHE B 234 -1 O ARG B 233 N LYS B 193
CISPEP 1 TRP A 101 PRO A 102 0 -8.95 CISPEP 2 TRP B 101 PRO B 102 0 0.12
SITE 1 AC1 16 ARG A 48 ARG A 51 LYS A 52 TRP A 53 SITE 2 AC1 16 GLU A 54 LYS A 100 ASN A 103 ALA A 104 SITE 3 AC1 16 LYS A 111 ASN A 131 ALA A 140 TYR A 227 SITE 4 AC1 16 BTN A1401 HOH A1494 HOH A1634 HOH A1670 SITE 1 AC2 15 GLY B 47 ARG B 48 ARG B 51 LYS B 52 SITE 2 AC2 15 TRP B 53 GLU B 54 LYS B 100 ASN B 103 SITE 3 AC2 15 LYS B 111 ASN B 131 ALA B 140 BTN B1402 SITE 4 AC2 15 HOH B1440 HOH B1582 HOH B1655 SITE 1 AC3 15 SER A 21 THR A 22 ASN A 23 GLN A 42 SITE 2 AC3 15 GLY A 45 HIS A 46 GLY A 47 TRP A 53 SITE 3 AC3 15 LEU A 62 ASN A 103 LYS A 111 GLY A 114 SITE 4 AC3 15 ILE A 128 GLY A 129 ATP A1301 SITE 1 AC4 17 SER B 21 THR B 22 ASN B 23 GLN B 42 SITE 2 AC4 17 GLY B 45 HIS B 46 GLY B 47 ARG B 48 SITE 3 AC4 17 TRP B 53 LEU B 62 ASN B 103 LYS B 111 SITE 4 AC4 17 GLY B 114 VAL B 115 ILE B 128 GLY B 129 SITE 5 AC4 17 ATP B1302
CRYST1 38.134 82.826 72.220 90.00 102.53 90.00 P 1 21 1 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.026223 0.000000 0.005828 0.00000
SCALE2 0.000000 0.012074 0.000000 0.00000
SCALE3 0.000000 0.000000 0.014184 0.00000